🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
MorphoSys Research Site
Start Date
2021-05-11
Trial ID
NCT04824092
Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2020-05-21
Trial ID
NCT04231448
The purpose of this study is to evaluate the safety and efficacy of orelabr...
Status
Unknown
Location
The first affiliated hospital of bengbu medical college
Start Date
2022-11-02
Trial ID
NCT05234684
Treatments Being Tested
Phase 3 randomized, double-blind, placebo-controlled, study assessing the e...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-10-08
Trial ID
NCT04529772
Treatments Being Tested
This trial is to evaluate if dexrazoxane is safer and more effective than l...
Status
Recruiting
Location
Beth Israel Deaconess Medical Center
Start Date
2026-08-31
Trial ID
NCT07654426
Phase III study of RAD001 adjuvant therapy in poor risk patients with Diffu...
Status
Completed
Location
Ironwood Cancer and Research Centers SC
Start Date
2009-07-24
Trial ID
NCT00790036
Treatments Being Tested
This Phase III, randomized, double-blind, placebo-controlled study will com...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-11-16
Trial ID
NCT03274492
The purpose of this study is to evaluate the efficacy and safety of PCI-327...
Status
Completed
Location
Multiple Locations
Start Date
2014-01-31
Trial ID
NCT01974440
The purpose of this study is to assess whether copanlisib in combination wi...
Status
Terminated
Location
Ironwood Physicians P.C. DBA Ironwood Cancer & Res. Ctr.
Start Date
2016-01-06
Trial ID
NCT02626455
To determine whether armodafinil is more effective than placebo in reducing...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01044004
Treatments Being Tested